Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes
Companies expect products to hit the Brazilian market in October 10/01/2025 Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes — Photo: Pexels Danish pharmaceutical company Novo Nordisk and Brazil’s Eurofarma announced on Wednesday (1) a partnership to launch two new brands of injectable biological semaglutide in Brazil for the treatment of obesity […]
